Prestige BioPharma Limited

KOSE:A950210 Stock Report

Market Cap: ₩177.3b

Prestige BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A950210?
Owner TypeNumber of SharesOwnership Percentage
Institutions11,7030.0974%
Individual Insiders3,653,72630.4%
General Public3,823,94131.8%
Private Companies4,529,86137.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 68.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.7%
Mayson Partners Pte. Ltd.
2,602,074₩38.4b0%no data
16%
Octava Fund Limited
1,927,787₩28.4b0%no data
15.4%
So-Yeon Park
1,851,256₩27.3b0%no data
14.9%
Jinwoo Kim
1,795,720₩26.5b0%no data
0.097%
State Street Global Advisors, Inc.
11,703₩172.6m2.54%no data
0.05%
Ting Tan
6,000₩88.5m0%no data
0.0033%
Seok-jae Seo
400₩5.9m0%no data
0.0029%
Kyunghui Jeon
350₩5.2m0%no data